Zhou HH - Search Results

1

Drug-induced hyperglycaemia and diabetes: pharmacogenomics perspectives.

Liu MZ, He HY, Luo JQ, He FZ, Chen ZR, Liu YP, Xiang DX, Zhou HH, Zhang W. Liu MZ, et al. Among authors: zhou hh. Arch Pharm Res. 2018 Jul;41(7):725-736. doi: 10.1007/s12272-018-1039-x. Epub 2018 Jun 1. Arch Pharm Res. 2018. PMID: 29858981 Review.

2

CYP2C9 allele variants in Chinese hypertension patients and healthy controls.

Yu BN, Luo CH, Wang D, Wang A, Li Z, Zhang W, Mo W, Zhou HH. Yu BN, et al. Among authors: zhou hh. Clin Chim Acta. 2004 Oct;348(1-2):57-61. doi: 10.1016/j.cccn.2004.04.028. Clin Chim Acta. 2004. PMID: 15369736

3

Ile118Val genetic polymorphism of CYP3A4 and its effects on lipid-lowering efficacy of simvastatin in Chinese hyperlipidemic patients.

Wang A, Yu BN, Luo CH, Tan ZR, Zhou G, Wang LS, Zhang W, Li Z, Liu J, Zhou HH. Wang A, et al. Among authors: zhou g, zhou hh. Eur J Clin Pharmacol. 2005 Feb;60(12):843-8. doi: 10.1007/s00228-004-0848-7. Epub 2005 Jan 14. Eur J Clin Pharmacol. 2005. PMID: 15650881 Clinical Trial.

4

T102C genetic polymorphism of the 5-HT2A receptor in Chinese hypertensive patients and healthy controls.

Yu BN, Wang A, Zhou G, Zhang W, Hu DL, Li Q, He YJ, Zhou HH. Yu BN, et al. Among authors: zhou g, zhou hh. Clin Exp Pharmacol Physiol. 2004 Dec;31(12):847-9. doi: 10.1111/j.1440-1681.2004.04124.x. Clin Exp Pharmacol Physiol. 2004. PMID: 15659047

5

MDR1 genotype do not influence the absorption of a single oral dose of 100 mg talinolol in healthy Chinese males.

Zhang WX, Chen GL, Zhang W, Tan ZR, Liu J, Zhou G, Hu DL, Zhou HH. Zhang WX, et al. Among authors: zhou g, zhou hh. Clin Chim Acta. 2005 Sep;359(1-2):46-52. doi: 10.1016/j.cccn.2005.03.010. Clin Chim Acta. 2005. PMID: 16170863

6

Effect of the CYP2C9*3 allele on lornoxicam metabolism.

Liu YL, Zhang W, Tan ZR, Ouyang DS, Luo CH, Liu ZQ, Qiu Y, Chen Y, He YJ, Zhou G, Zhou HH. Liu YL, et al. Among authors: zhou g, zhou hh. Clin Chim Acta. 2006 Feb;364(1-2):287-91. doi: 10.1016/j.cca.2005.07.013. Epub 2005 Sep 22. Clin Chim Acta. 2006. PMID: 16182270

7

Role of BCRP 421C>A polymorphism on rosuvastatin pharmacokinetics in healthy Chinese males.

Zhang W, Yu BN, He YJ, Fan L, Li Q, Liu ZQ, Wang A, Liu YL, Tan ZR, Fen-Jiang, Huang YF, Zhou HH. Zhang W, et al. Among authors: zhou hh. Clin Chim Acta. 2006 Nov;373(1-2):99-103. doi: 10.1016/j.cca.2006.05.010. Epub 2006 May 13. Clin Chim Acta. 2006. PMID: 16784736

8

Effect of SLCO1B1 genetic polymorphism on the pharmacokinetics of nateglinide.

Zhang W, He YJ, Han CT, Liu ZQ, Li Q, Fan L, Tan ZR, Zhang WX, Yu BN, Wang D, Hu DL, Zhou HH. Zhang W, et al. Among authors: zhou hh. Br J Clin Pharmacol. 2006 Nov;62(5):567-72. doi: 10.1111/j.1365-2125.2006.02686.x. Epub 2006 Jun 23. Br J Clin Pharmacol. 2006. PMID: 16796707 Free PMC article.

9

Sensitive and selective liquid chromatography-mass spectrometry method for the quantification of rosiglitazone in human plasma.

He J, Hu YF, Duan LF, Tan ZR, Wang LS, Wang D, Zhang W, Li Z, Liu J, Tu JH, Yao YM, Zhou HH. He J, et al. Among authors: zhou hh. J Pharm Biomed Anal. 2007 Jan 17;43(2):580-5. doi: 10.1016/j.jpba.2006.07.010. Epub 2006 Aug 24. J Pharm Biomed Anal. 2007. PMID: 16934427 Clinical Trial.

10

SLCO1B1 521T-->C functional genetic polymorphism and lipid-lowering efficacy of multiple-dose pravastatin in Chinese coronary heart disease patients.

Zhang W, Chen BL, Ozdemir V, He YJ, Zhou G, Peng DD, Deng S, Xie QY, Xie W, Xu LY, Wang LC, Fan L, Wang A, Zhou HH. Zhang W, et al. Among authors: zhou g, zhou hh. Br J Clin Pharmacol. 2007 Sep;64(3):346-52. doi: 10.1111/j.1365-2125.2007.02892.x. Epub 2007 Apr 18. Br J Clin Pharmacol. 2007. PMID: 17439540 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

711 results

Search Page